Related Experiment Video
Updated: Apr 21, 2026
The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
Published on: June 1, 2019
A review of sentinel lymph node biopsy for thin melanoma
K M Joyce1, N M McInerney, C W Joyce
1Department of Plastic and Reconstructive Surgery, Galway University Hospital, Galway, Ireland, kennethjoyce1@gmail.com.
Introduction:
Although there is a lack of established survival benefit of sentinel lymph node biopsy (SLNB), this technique has been increasingly applied in the staging of patients with thin (≤1.00 mm) melanoma (T1Nx), without clear supportive evidence.
Methods:
We review the guidelines and available literature on the indications and rationale for performing SLNB in thin melanoma.
Results:
As a consequence of the paucity of evidence of SLNB in thin melanoma, there is considerable variability in the guidelines. It is difficult to define clinicopathologic factors that reliably predict the presence of nodal metastasis. SLNB does not yet inform management in thin melanoma to improve survival outcome.
Conclusion:
Based on available evidence, high risk patients with melanomas between 0.75 and 1.00 mm may be appropriate candidates to be considered for SLN biopsy after discussing the likelihood of finding evidence of nodal progression, the risks of sentinel node biopsy, and the lack of proven survival benefit from any form of surgical nodal staging.
